CAD 0.05
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -4.54 Million | -9.88 Million | -5.88 Million | -4.35 Million | -7.71 Million | -7.84 Million |
Net Income | -10.71 Million | -13.34 Million | -6.2 Million | -5.48 Million | -7.98 Million | -8.06 Million |
Depreciation & Amortization | 144.11 Thousand | 46.87 Thousand | 59.5 Thousand | 97.45 Thousand | 103.88 Thousand | 101.42 Thousand |
Deferred income taxes | -1.24 Million | - | 428.82 Thousand | 1.24 Million | 882.99 Thousand | 362.22 Thousand |
Stock-based compensation | 943.34 Thousand | 1.04 Million | 1.97 Million | 818.03 Thousand | 341.46 Thousand | 1.08 Million |
Change in working capital | 214.21 Thousand | -271.08 Thousand | -1.9 Million | -725.51 Thousand | -93.08 Thousand | -240.72 Thousand |
Other non-cash items | 6.11 Million | 2.64 Million | -236.67 Thousand | -305.9 Thousand | -966.65 Thousand | -1.09 Million |
Investing Cash Flow | 1.82 Million | 3.52 Million | -3917.00 | 5.06 Million | 1.42 Million | -11.75 Million |
Investments in PPE | -42.17 Thousand | -15.34 Thousand | -15.15 Thousand | -8555.00 | -180.4 Thousand | -1.75 Million |
Acquisitions | - | - | - | - | 380.32 Thousand | - |
Investment purchases | - | - | - | - | -1.92 Million | - |
Sales/Maturities of investments | 1.62 Million | - | - | - | 1.97 Million | - |
Other Investing Activities | 244.11 Thousand | 3.54 Million | 11.23 Thousand | 5.07 Million | 1.17 Million | -10 Million |
Financing Cash Flow | -9651.00 | -117.67 Thousand | -16.77 Thousand | 1.21 Million | -93.87 Thousand | -10.08 Million |
Debt repayment | -9651.00 | -18.17 Thousand | -16.77 Thousand | -20.58 Thousand | -19.92 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -99.5 Thousand | - | -183.34 Thousand | -949.74 Thousand | -10.08 Million |
Common Stock Issuance | - | - | - | 1.41 Million | 875.8 Thousand | - |
Other Financing Activities | -9651.00 | -117.67 | -16.77 | 1.41 Million | 875.8 Thousand | -4.96 Million |
Accounts receivables | -14.54 Thousand | 67.82 Thousand | -130.8 Thousand | -1280.00 | 32.62 Thousand | 25.1 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 228.76 Thousand | -338.9 Thousand | -1.77 Million | -724.23 Thousand | -125.7 Thousand | -265.82 Thousand |
Cash at beginning of period | 17.58 Million | 23.96 Million | 30 Million | 28.96 Million | 35.37 Million | 65.09 Million |
Cash at end of period | 15.1 Million | 17.58 Million | 23.96 Million | 30 Million | 28.96 Million | 35.37 Million |
Capital Expenditure | -42.17 Thousand | -15.34 Thousand | -15.15 Thousand | -8555.00 | -180.4 Thousand | -1.75 Million |
Effect of forex changes on cash | 248.13 Thousand | 95.26 Thousand | -134.45 Thousand | -882.3 Thousand | -31.28 Thousand | -26.34 Thousand |
Net cash flow / Change in cash | -2.48 Million | -6.37 Million | -6.04 Million | 1.04 Million | -6.41 Million | -29.71 Million |
Free Cash Flow | -4.59 Million | -9.9 Million | -5.9 Million | -4.36 Million | -7.89 Million | -9.6 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.71 Million | -1.37 Million | -6.59 Million | -10.71 Million | -1.48 Million | -1.53 Million |
Depreciation & Amortization | 9823.00 | 10.23 Thousand | 114.41 Thousand | 144.11 Thousand | 3409.00 | 15.18 Thousand |
Deferred income taxes | - | - | -2.08 Million | -1.24 Million | 405.21 Thousand | 135.27 Thousand |
Stock-based compensation | 67.31 Thousand | 69.18 Thousand | 140.34 Thousand | 943.34 Thousand | 257.34 Thousand | 383.59 Thousand |
Change in working capital | 963.17 Thousand | 226.64 Thousand | -1.74 Million | 214.21 Thousand | 89.87 Thousand | 237.78 Thousand |
Other non-cash items | 368.01 Thousand | -100.95 Thousand | 7.12 Million | 6.11 Million | -272.1 Thousand | -257.99 Thousand |
Investing Cash Flow | - | - | 1.62 Million | 1.82 Million | -39.25 Thousand | 319.03 Thousand |
Investments in PPE | - | - | 938.00 | -42.17 Thousand | -39.25 Thousand | -965.00 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 1.62 Million | 1.62 Million | - | - |
Other Investing Activities | - | - | 1625.28 | 244.11 Thousand | - | 320 Thousand |
Financing Cash Flow | - | - | -697.00 | -9651.00 | -1059.00 | -2893.00 |
Debt repayment | - | - | -697.00 | -9651.00 | -1059.00 | -2893.00 |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -1.06 | -2.89 |
Accounts receivables | 6210.00 | 40.63 Thousand | -1.71 Million | -14.54 Thousand | 20.94 Thousand | 101.26 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 956.96 Thousand | 186.01 Thousand | -25.08 Thousand | 228.76 Thousand | 68.93 Thousand | 136.52 Thousand |
Cash at beginning of period | 14.09 Million | 15.1 Million | 16.47 Million | 17.58 Million | 17.57 Million | 18.21 Million |
Cash at end of period | 12.49 Million | 14.09 Million | 15.1 Million | 15.1 Million | 16.47 Million | 17.57 Million |
Capital Expenditure | - | - | 938.00 | -42.17 Thousand | -39.25 Thousand | -965.00 |
Effect of forex changes on cash | -209.6 Thousand | 212.15 Thousand | 49 Thousand | 248.13 Thousand | -63.22 Thousand | 67.36 Thousand |
Net cash flow / Change in cash | -1.6 Million | -1 Million | -1.36 Million | -2.48 Million | -1.1 Million | -640.42 Thousand |
Free Cash Flow | -1.39 Million | -1.21 Million | -3.04 Million | -4.59 Million | -1.03 Million | -1.02 Million |
VSTTILLERS
TRIP
DRUG
ELAB
300175
6412